Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, A.
Right arrow Articles by Bartlett, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, A.
Right arrow Articles by Bartlett, S. J.
(Chest. 2006;130:1034-1038.)
© 2006 American College of Chest Physicians

Depressive Symptoms and Adherence to Asthma Therapy After Hospital Discharge*

Amena Smith, BS; Jerry A. Krishnan, MD, PhD, FCCP; Andrew Bilderback, MS; Kristin A. Riekert, PhD; Cynthia S. Rand, PhD and Susan J. Bartlett, PhD

* From the Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health, Baltimore MD.

Correspondence to: Susan J. Bartlett, PhD, Johns Hopkins AAC, 5501 Hopkins Bayview 1B.15, Baltimore, MD 21224; e-mail: bartlett{at}jhmi.edu

Abstract

Study objectives: To evaluate the effect of depressive symptoms on adherence to therapy after discharge in patients hospitalized for asthma exacerbations.

Design: Prospective cohort study in which depressive symptoms were assessed during hospitalization and use of asthma medications was electronically monitored for 2 weeks after discharge.

Setting: Inner-city academic hospital in Baltimore, MD.

Patients: Patients were 59 adults with a mean age of 43.2 ± 10.9 years (± SD), who were mostly female (64%), African American (80%), and were hospitalized for an asthma exacerbation.

Measurement and results: Depressive symptoms were assessed with the Center for Epidemiological Studies-Depression scale. Electronic monitors were used to evaluate inhaled corticosteroid and oral corticosteroid use for up to 2 weeks after discharge. Forty-one percent of patients had high levels of depressive symptoms. Mean adherence to therapy was significantly lower in patients with (vs without) high levels of depressive symptoms (60 ± 26% vs 74 ± 21%, p + 0.02). Even after controlling for age, gender, and education, depressive symptoms were a significant and independent predictor of poorer adherence. High levels of depressive symptoms were associated with a 11.4-fold increase (95% confidence interval, 2.2 to 58.2) in the odds of poor adherence to therapy after adjustment for potential confounders.

Conclusions: Depressive symptoms are common in inner-city adults hospitalized for asthma exacerbations and identify a subset of patients at high risk for poor adherence to asthma therapy after discharge. Further research is needed to determine if screening for and treating depression improves adherence and asthma outcomes in this population.

Key Words: adherence • asthma • depression • inner city




This article has been cited by other articles:


Home page
ChestHome page
K. A. Riekert, S. J. Bartlett, M. P. Boyle, J. A. Krishnan, and C. S. Rand
The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis
Chest, July 1, 2007; 132(1): 231 - 237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.